Related Experiment Video
Updated: May 20, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Damage-associated molecular patterns (DAMPs) in vascular diseases.
1Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Damage-associated molecular patterns (DAMPs) drive chronic sterile inflammation in vascular diseases. Targeting DAMPs and their signaling pathways shows promise for treating conditions like atherosclerosis and hypertension.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Chronic sterile inflammation is increasingly recognized as a key driver of vascular disease progression.
- Damage-associated molecular patterns (DAMPs) act as crucial mediators, linking cardiovascular risk factors to inflammatory responses.
- Understanding DAMPs and their signaling is vital for developing novel therapeutic strategies.
Purpose of the Study:
- To review the role of DAMPs and their associated receptor signaling pathways in vascular disease.
- To summarize how DAMPs contribute to pro-inflammatory cytokine release and vascular remodeling.
- To discuss the clinical implications and future directions for targeting DAMPs in vascular pathologies.
Main Methods:
- Literature review of studies on DAMPs and vascular disease.
- Analysis of signaling pathways including TLRs, RAGE, cGAS-STING, and NLRP3 inflammasome.
- Examination of pre-clinical and clinical trial data targeting DAMPs.
Main Results:
- DAMPs activate key signaling pathways that promote inflammation and vascular remodeling.
- Specific DAMP-mediated pathways are implicated in atherosclerosis, fibrosis, aneurysm, ischemia, and hypertension.
- Targeting DAMPs has shown potential in pre-clinical and clinical studies.
Conclusions:
- DAMPs are central players in sterile inflammation underlying vascular diseases.
- Modulating DAMP signaling pathways offers a promising therapeutic avenue for vascular conditions.
- Further research and clinical trials are warranted to fully exploit the therapeutic potential of targeting DAMPs.
Related Concept Videos
Vascular Spasm
Inflammation
Cardiovascular Drugs: Classification based on Therapeutic Indications
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Overview of the Vascular System
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

